SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?
about
Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsLow-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controllerMurine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.Functional effector memory T cells contribute to protection from superinfection with heterologous simian immunodeficiency virus or simian-human immunodeficiency virus isolates in Chinese rhesus macaques.
P2860
SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SHIV infection protects agains ...... for HIV-1 vaccine development?
@en
SHIV infection protects agains ...... for HIV-1 vaccine development?
@nl
type
label
SHIV infection protects agains ...... for HIV-1 vaccine development?
@en
SHIV infection protects agains ...... for HIV-1 vaccine development?
@nl
prefLabel
SHIV infection protects agains ...... for HIV-1 vaccine development?
@en
SHIV infection protects agains ...... for HIV-1 vaccine development?
@nl
P2093
P2860
P1433
P1476
SHIV infection protects agains ...... for HIV-1 vaccine development?
@en
P2093
James Blanchard
Julia L Hurwitz
Louis Martin
Robert Sealy
Timothy D Lockey
Xiaoyan Zhan
P2860
P304
P356
10.2174/157016209789346255
P577
2009-09-01T00:00:00Z